Restoration of nocturnal dip in blood pressure is associated with improvement in left ventricular ejection fraction. A 1-year clinical study comparing the effects of Amlodipine and Nifedipine retard on ambulatory blood pressure and left ventricular systolic function in Chinese hypertensive type 2 diabetic patients

International Journal of Cardiology

Volumn 89, Issue 2-3, 2003, Pages 159-166

  Ko, Gary T C ^a   Chan, Hamish C K ^a  

^a ALICE HO MIU LING NETHERSOLE HOSPITAL   (Hong Kong)

Author keywords

Ambulatory blood pressure; Chinese; Diabetes mellitus; Hypertension; Left ventricular systolic function; Nocturnal dip

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; NIFEDIPINE;

ADULT; AGED; ANKLE EDEMA; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CHINESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC HYPERTENSION; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ECHOCARDIOGRAPHY; FEMALE; FLUSHING; HEADACHE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VERTIGO;

EID: 0037722815     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(02)00450-3     Document Type: Article

References (23)

1. Marler J.R., Price T.R., Clark G.L., et al. Morning increase in onset of ischemic stroke. Stroke. 20:1989;473-476.
2. Willich S.N., Goldberg R.J., Maclure M., Perriello L., Muller J.E. Increased onset of sudden cardiac death in the first 3 h after awakening. Am J Cardiol. 70:1992;65-68.
3. Coats A.J.S., Clark S., Conway J. Analysis of ambulatory blood pressure data. J Hypertens. 9:(Suppl 8):1991;S19-S21.
4. Staessen J., Celis H., De Cort P., Fagard R., Thijs L., Amery A. Methods for describing the diurnal blood pressure curve. J Hypertens. 9:(Suppl 8):1991;S16-S18.
5. O'Brien E., Sheridan J., O'Malley K. Dippers and non-dippers (letter). Lancet. ii:1998;397.
6. Verdeccia P., Schillaci G., Gueniere M., et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation. 81:1990;528-536.
7. Palatini P., Penzo M., Racioppa A., et al. Clinical relevance of nighttime blood pressure and of daytime blood pressure variability. Arch Intern Med. 152:1992;1855-1860.
8. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 157:1997;2413-2446.
9. Zachariah P.K., Sheps S.G., Ilstrup D.M., et al. Blood pressure load, a better determinant of hypertension. Mayo Clin Proc. 63:1988;1085-1091.
10. Verdecchia P., Porcellati C., Schillaci G., et al. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension. 24:1994;793-801.
11. Fuller J.H., Head J. Blood pressure, proteinuria and their relationship with circulatory mortality: the WHO multinational study of vascular disease in diabetics. Diabet Metab. 15:1989;273-277.
12. Executive summary of the third report of the National Cholesterol Education Program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc 2001;285:2486-97.
13. Deverux R.B., Reichek N. Echocardiographic determination of left ventricular mass in men: anatomic validation of the method. Circulation. 55:1977;613-618.
14. Staessen J.A., Fagard R., Thijs L., et al. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 350:1997;757-764.
15. Gong L., Zhang W., Zhu Y., et al. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens. 14:1996;1237-1245.
16. Liu L., Wang J.G., Gong L., Liu G., Staessen J.A. Comparison of active treatment and placebo for older Chinese patients with isolated systolic hypertension. J Hypertens. 16:1998;1823-1829.
17. Grossman E., Messerli F.H., Goldbourt U. High blood pressure and diabetes mellitus: are all antihypertensive drugs created equal? Arch Intern Med. 160:2000;2447-2452.
18. Baumgart P., Walger P., Gerke M., Dorst K.G., Vetter H., Rahn K.H. Nocturnal hypertension in renal failure, haemodialysis and after renal transplantation. J Hypertens. 7:(Suppl 6):1989;S70-S71.
19. Littler W.A., Honour A.J., Carter R.D., Sleight P. Sleep and blood pressure. Br Med J. 3:1975;346-348.
20. Willich S.N., Jimenez A.H., Tofler G.H., DeSilva R.A., Muller J.E. Pathophysiology and triggers of acute myocardial infarction: clinical implications. Clin Invest. 70:(Suppl 1):1992;S73-S78.
21. Gruickshank J.M. Reversibility of left ventricular hypertrophy (LVH) by differing types of antihypertensive therapy. J Hum Hypertens. 6:1992;85-90.
22. Dahlof B., Pennert K., Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A meta-analysis of 109 treatment studies. Am J Hypertens. 5:1992;95-110.
23. Gonzalez-Juanatey J.R., Pose Reino A., Garcia Acuna J.M., et al. Left ventricular systolic function after marked reduction of ventricular hypertrophy induced by 5 years' enalapril treatment. Eur Heart J. 16:1995;1981-1987.